Objective:To explore the differential diagnostic value of three gastric function indicators and Helicobacter pylori ( Hp) antibody combined detection in early gastric cancer and precancerous lesions. Methods:A total of 103 patients with gastric cancer (gastric cancer group), 103 patients with precancerous lesions (precancerous lesion group) and 103 healthy physical examination subjects (healthy group) admitted to the Emergency Management Department Emergency General Hospital from December 2020 to December 2022 were retrospectively selected as the study objects. Three gastric function tests and 14C breath test were performed in all three groups. The levels of three gastric function indicators and Hp antibody were compared among the three groups. According to the results of 14C breath test, gastric cancer patients were divided into the positive group and the negative group, and the levels of the three gastric function indicators were compared between the two groups. Results:The serum levels of pepsinogen Ⅱ (PGⅡ) and gastrin 17 (G-17) in the gastric cancer group were higher than those in the precancerous lesion group and healthy group: (18.32 ± 4.72) μg/L vs. (13.83 ± 3.63), (11.56 ± 3.47) μg/L; (74.82 ± 8.89) μg/L vs. (61.07 ± 7.51), (49.14 ± 5.29) μg/L; the levels of pepsinogen Ⅰ (PGⅠ) and pepsinogen ratio (PGR, PGⅠ/ PGⅡ) were lower than those in the precancerous lesion group and healthy group: (35.83 ± 5.93) μg/L vs. (73.05 ± 7.23), (86.27 ± 8.48) μg/L; 1.96 ± 0.54 vs. 5.28 ± 1.00, 7.46 ± 1.02, there were statistical differences ( P<0.05). The positive rates of Hp antibody in gastric cancer group, precancerous lesion group and healthy group were 65.05% (67/103), 33.01%(34/103) and 11.65% (12/103), respectively, there was a statistically significant difference in the positive rates of Hp antibody among the three groups ( χ2 = 64.15, P<0.05). The positive rate of Hp antibody was the highest in gastric cancer group, followed by precancer group, and the lowest in healthy group.The levels of PGⅠand PGR in patients with positive 14C breath test in the gastric cancer group were lower than those with negative results: (25.79 ± 3.63) μg/L vs. (41.82 ± 4.71) μg/L, 1.28 ± 0.42 vs. 2.40 ± 0.56, while the levels of PGⅡ and G-17 were higher than those with negative results: (20.35 ± 3.59) μg/L vs. (17.46 ± 3.52) μg/L, (83.72 ± 10.84) μg/L vs. (65.07 ± 7.76) μg/L, there were statistical differences ( P<0.05). Conclusions:The combined detection of gastric function and Hp antibody can serve as important screening indicator for evaluating gastric cancer and precancerous lesions.

Objective:To explore the differential diagnostic value of three gastric function indicators and Helicobacter pylori ( Hp) antibody combined detection in early gastric cancer and precancerous lesions. Methods:A total of 103 patients with gastric cancer (gastric cancer group), 103 patients with precancerous lesions (precancerous lesion group) and 103 healthy physical examination subjects (healthy group) admitted to the Emergency Management Department Emergency General Hospital from December 2020 to December 2022 were retrospectively selected as the study objects. Three gastric function tests and 14C breath test were performed in all three groups. The levels of three gastric function indicators and Hp antibody were compared among the three groups. According to the results of 14C breath test, gastric cancer patients were divided into the positive group and the negative group, and the levels of the three gastric function indicators were compared between the two groups. Results:The serum levels of pepsinogen Ⅱ (PGⅡ) and gastrin 17 (G-17) in the gastric cancer group were higher than those in the precancerous lesion group and healthy group: (18.32 ± 4.72) μg/L vs. (13.83 ± 3.63), (11.56 ± 3.47) μg/L; (74.82 ± 8.89) μg/L vs. (61.07 ± 7.51), (49.14 ± 5.29) μg/L; the levels of pepsinogen Ⅰ (PGⅠ) and pepsinogen ratio (PGR, PGⅠ/ PGⅡ) were lower than those in the precancerous lesion group and healthy group: (35.83 ± 5.93) μg/L vs. (73.05 ± 7.23), (86.27 ± 8.48) μg/L; 1.96 ± 0.54 vs. 5.28 ± 1.00, 7.46 ± 1.02, there were statistical differences ( P<0.05). The positive rates of Hp antibody in gastric cancer group, precancerous lesion group and healthy group were 65.05% (67/103), 33.01%(34/103) and 11.65% (12/103), respectively, there was a statistically significant difference in the positive rates of Hp antibody among the three groups ( χ2 = 64.15, P<0.05). The positive rate of Hp antibody was the highest in gastric cancer group, followed by precancer group, and the lowest in healthy group.The levels of PGⅠand PGR in patients with positive 14C breath test in the gastric cancer group were lower than those with negative results: (25.79 ± 3.63) μg/L vs. (41.82 ± 4.71) μg/L, 1.28 ± 0.42 vs. 2.40 ± 0.56, while the levels of PGⅡ and G-17 were higher than those with negative results: (20.35 ± 3.59) μg/L vs. (17.46 ± 3.52) μg/L, (83.72 ± 10.84) μg/L vs. (65.07 ± 7.76) μg/L, there were statistical differences ( P<0.05). Conclusions:The combined detection of gastric function and Hp antibody can serve as important screening indicator for evaluating gastric cancer and precancerous lesions.

Objective:To assess the prevalence of metabolic syndrome(MS) and its relationship with hyperuricemia(HUA) in perimenopausal women in Anning city, Yunnan province.Methods:This is a cross-sectional survey. In May 2021, a multi-stage stratified sampling method was used to collect demographics and clinical data [ethnicity, living community, height, weight, waist circumference, blood pressure, fasting plasma glucose, triglycerides(TG), serum uric acid, high density lipoprotein-cholesterol(HDL-C), alanine transaminase(ALT), etc] in a total of 6 721 perimenopausal women aged 45-60 years.Results:A total of 6 721 perimenopausal women were included in this study. The prevalences of MS and HUA were 14.05%(95% CI 13.22%-14.88%) and 6.46%(95% CI 5.88%-7.07%), respectively. The average age, HDL-C, urea, direct bilirubin, and albumin levels in the perimenstrual HUA population were lower than those in the non-HUA population while the levels of TG, ALT, heart rate, body mass index(BMI), and creatinine were higher(all P<0.05). The prevalence of HUA in perimenopausal women with ethnic minorities and family history of chronic diseases was higher than that in Han nationality and without family history of chronic diseases. The prevalence of MS in perimenopausal women was increased with the increase of serum uric acid( Z=-15.313 8, P<0.001). Multivariate logistic regression model showed that HUA was positively correlated with MS( OR=1.526, 95% CI 1.192-1.954) after adjusting for covariates such as BMI and ethnicity, and the incidence of MS in perimenopausal women in HUA group was 1.526 folds higher than that in non-hyperuricemia group. Conclusion:HUA is highly positively correlated with MS in perimenopausal women. The management of uric acid level in perimenopausal women should be strengthened.

Objective To investigate the correlation between tumor perfusion parameters and tumor volume and Child-Pugh classification in CT of hepatocellular carcinoma (HCC).Methods Fifty-six patients with hepatocellular carcinoma were selected to perform CT perfusion imaging.The parameters of the total tumor perfusion such as hepatic artery perfusion (HAP),portal vein perfusion (PVP)and hepatic perfusion index (HAPI)were calculated according to the degree of hepatic encephalopathy,albumin,bilirubin, clotting time,ascites for liver Child-Pugh classification.The relationship between the tumor or peritumoral perfusion parameters with tumor volume and Child-Pugh classification were analyzed.Results (1)There was no correlation between tumor or peritumoral perfusion with the tumor volume.(2)The difference of HAP,PVP and HAPI between the different Child-Pugh classification groups was statistically significant (P<0.000 1).(3)With the reduction of Child-Pugh classification,the tumor body HAP and HAPI values gradually decreased, while the PVP value increased gradually.Conclusion There is no correlation between the tumor volume of hepatocellular carcinoma with total tumor perfusion parameters.The differences in perfusion measurements between different Child-Pugh classification can intuitively and quantitatively reflect the reserve function of the liver.

Objective: To investigate the effect of different mechanisms of liver-protection drugs in clinic and compare which one is best for the proliferation of irradiated HL-7702, laying the basis of liver-protection drugs choose in clinic on theory and practice. Methods: Human liver parenchyma cells HL-7702 were given single 6 MV X ray irradiation at a dose of 10Gy, the cells’ morphology were detected under an inverted microscope at 24h, 48h and 72h. Then, MTT was used to assess the survival rate of the cells to evaluate the effect of the X ray. The representive medicines which mechanism may relate to RILD were chosen and diluted into various concentrations with culture medium according to clinical and relative reports. Different concentrations of medicines were used to protect the cells damaged by the X ray. Comparing the effect with MTT and measure SOD, MDA for the best one. Further research on its protection of oxidative damage. T-test, F test and non- paramiter test were used for statistical analysis. Results: 2.5 mg/ml and 1 mg/ml of magnesium isoglycyrrhizinate both have an effect on the proliferation of liver cells, especially the concentration of 1 mg/ml. The injection of polyene phosphatidyl choline show trivial effect at the concentrations of 250 μmol/L and reduced glutathione(GSH) did not demonstrate relative functions. Further research on the magnesium isoglycyrrhizinate, found its protection at 48h to oxidative damage (P < 0.05), but the effect is weak at 24h and 48h. Conclusions In three kinds of representing medicines, magnesium isoglycyrrhizinate has preferable effects on liver parenchyma cells and show a bright future in the treatment of RILD.

Objective To investigate the clinical significance of flow cytometry (FCM) assay in following up of the minimal residual disease (MRD) used for predicting relapse and guiding chemotherapy. Methods The clinical data of 43 acute leukemia patients diagnosed by MIC were collected in our hospital from 2005 July to 2008 June.Bone marrow aspirates were collected from 43 patients with newly diagnosed acute leukemia after induction therapy and during constimulation therapy. The cells with leukemia associated with immunophenotype were investigated using FCM, as immunologic target of MRD. Results MRD were detected earlier in predicting the relapse than those of the traditional bone marrow cells morphology assay by an average of 4-6 months. The results of the MRD following up: MRD was negative at CR in 26 cases, 6 cases relapse, 20 cases of them were kept negative during following up. MRD was positive in 17 cases at CR, 9 cases of them were relapse. 4 cases after intensified chemotherapy the MRD became negative and kept egative for more than one year. The MRD of the 43 cases at CR were divided into 3 groups, MRD less than 1×10-4 group (A group) MRD between 5×10-3 and 1×10-4 group (B group) and MRD above 5×10-3 group(C group). By chi square test. There was no statistical significance between A group and B group, but there was tatistical significance between B group and C group (P=0.02). Conclusion The application of FCM in detecting MRD has important clinical significance in predicting relapse and guiding chemotherapy.